Business Description
Bcworldpharm Co Ltd
ISIN : KR7200780005
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 1.14 | |||||
Debt-to-EBITDA | 9.92 | |||||
Interest Coverage | 0.09 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.75 | |||||
Beneish M-Score | -3.03 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10 | |||||
3-Year EBITDA Growth Rate | 50.1 | |||||
3-Year Book Growth Rate | -0.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 94.37 | |||||
9-Day RSI | 82.34 | |||||
14-Day RSI | 72.95 | |||||
6-1 Month Momentum % | -19.62 | |||||
12-1 Month Momentum % | -31.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.48 | |||||
Quick Ratio | 0.29 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 141.82 | |||||
Days Sales Outstanding | 82.34 | |||||
Days Payable | 31.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.03 | |||||
Forward Dividend Yield % | 2.23 | |||||
5-Year Yield-on-Cost % | 2.26 | |||||
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 9.43 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.77 | |||||
Operating Margin % | 0.59 | |||||
Net Margin % | -11.08 | |||||
FCF Margin % | 6.3 | |||||
ROE % | -10.08 | |||||
ROA % | -4.48 | |||||
ROIC % | 0.37 | |||||
ROC (Joel Greenblatt) % | 0.67 | |||||
ROCE % | 1.08 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.57 | |||||
PB Ratio | 0.54 | |||||
Price-to-Tangible-Book | 0.59 | |||||
Price-to-Free-Cash-Flow | 9.08 | |||||
Price-to-Operating-Cash-Flow | 5.8 | |||||
EV-to-EBIT | 123.55 | |||||
EV-to-EBITDA | 13.91 | |||||
EV-to-Revenue | 1.68 | |||||
EV-to-FCF | 26.17 | |||||
Price-to-Median-PS-Value | 0.21 | |||||
Earnings Yield (Greenblatt) % | 0.81 | |||||
FCF Yield % | 10.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bcworldpharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 72,883.64 | ||
EPS (TTM) (â‚©) | -870.001 | ||
Beta | 1.02 | ||
Volatility % | 16.22 | ||
14-Day RSI | 72.95 | ||
14-Day ATR (â‚©) | 158.031743 | ||
20-Day SMA (â‚©) | 4072.636363 | ||
12-1 Month Momentum % | -31.11 | ||
52-Week Range (â‚©) | 3536.363636 - 6781.818181 | ||
Shares Outstanding (Mil) | 9.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bcworldpharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bcworldpharm Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Bcworldpharm Co Ltd Frequently Asked Questions
What is Bcworldpharm Co Ltd(XKRX:200780)'s stock price today?
When is next earnings date of Bcworldpharm Co Ltd(XKRX:200780)?
Does Bcworldpharm Co Ltd(XKRX:200780) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |